Limits...
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.

Sandercock J, Parmar MK, Torri V, Qian W - Br. J. Cancer (2002)

Bottom Line: Four main explanations for this heterogeneity have been proposed: differences in the extent and timing of 'crossover' to taxanes in the control groups; differences in the types of patient included; differences in the effectiveness of the research regimens used; differences in the effectiveness of the control regimens used.Heterogeneity 'within' and 'between' groups was formally compared using the F-ratio.Further investigation of this question would be useful.

View Article: PubMed Central - PubMed

Affiliation: Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK.

Show MeSH

Related in: MedlinePlus

Results grouped by possible factors for heterogeneity.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2376171&req=5

fig2: Results grouped by possible factors for heterogeneity.

Mentions: Comparing groups with different amounts of crossover before progression (Figure 2Figure 2


First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.

Sandercock J, Parmar MK, Torri V, Qian W - Br. J. Cancer (2002)

Results grouped by possible factors for heterogeneity.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2376171&req=5

fig2: Results grouped by possible factors for heterogeneity.
Mentions: Comparing groups with different amounts of crossover before progression (Figure 2Figure 2

Bottom Line: Four main explanations for this heterogeneity have been proposed: differences in the extent and timing of 'crossover' to taxanes in the control groups; differences in the types of patient included; differences in the effectiveness of the research regimens used; differences in the effectiveness of the control regimens used.Heterogeneity 'within' and 'between' groups was formally compared using the F-ratio.Further investigation of this question would be useful.

View Article: PubMed Central - PubMed

Affiliation: Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK.

Show MeSH
Related in: MedlinePlus